Finance

Lists
Why is RAD down 25,00%?
Dive Deeper
RAD:ASX
Radiopharm Theranostics Ltd
0,0030 AUD
-25,00%
(-0,0010) 1D
17-ноя., 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RAD...
Open
0,00 AUD
High
0,00 AUD
Low
0,00 AUD
Mkt. cap
7,07 млн
Avg. vol.
6,24 млн
Volume
21,75 млн
52-wk high
0,04 AUD
52-wk low
0,00 AUD
EPS
-0,02 AUD
Shares outstanding
4,71 млд
No. of employees
14
Open
0,00 AUD
High
0,00 AUD
Low
0,00 AUD
Mkt. cap
7,07 млн
Avg. vol.
6,24 млн
Volume
21,75 млн
52-wk high
0,04 AUD
52-wk low
0,00 AUD
EPS
-0,02 AUD
Shares outstanding
4,71 млд
No. of employees
14
News stories
From web sources and news partners
About Radiopharm Theranostics Ltd
CEO-
Employees14
Founded2021
Headquarters-
SectorHealth Care
Industry-
Last report
2025-ж., 30-янв.
Fiscal period
Q2 2025
-0,01 USD / -0,01 USD
+9,57%beat
Revenue / Est. (USD)
859,04 миң / 0,00
+∞%beat
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,10 млн
3,10 млн
3,33 млн
3,33 млн
Cost of goods sold
11,30 млн
11,30 млн
12,30 млн
12,30 млн
Cost of revenue
11,30 млн
11,30 млн
12,30 млн
12,30 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,18 млн
4,18 млн
3,92 млн
3,92 млн
Operating expense
4,95 млн
4,95 млн
4,36 млн
4,36 млн
Total operating expenses
16,25 млн
16,25 млн
16,67 млн
16,67 млн
Operating income
-13,14 млн
-13,14 млн
-13,33 млн
-13,33 млн
Other non operating income
-
-
-
-
EBT including unusual items
-14,05 млн
-14,05 млн
-14,39 млн
-14,39 млн
EBT excluding unusual items
-13,37 млн
-13,37 млн
-13,18 млн
-13,18 млн
Income tax expense
67,15 миң
67,15 миң
-39,93 миң
-39,93 миң
Effective tax rate
-0,48%
-0,48%
0,28%
0,28%
Other operating expenses
-
-
-
-
Net income
-13,48 млн
-13,48 млн
-14,99 млн
-14,99 млн
Net profit margin
-434,67%
-434,67%
-450,12%
-450,12%
Earnings per share
-
-
-
-
Interest and investment income
-
-
318,57 миң
318,57 миң
Interest expense
-32,55 миң
-32,55 миң
-23,64 миң
-23,64 миң
Net interest expenses
-32,55 миң
-32,55 миң
294,93 миң
294,93 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,47 млн
-12,47 млн
-12,66 млн
-12,66 млн
Gain or loss from assets sale
-
-
106,38 миң
106,38 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору